The group’s principle activity is to provide full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology and oncology-related studies. The group’s services include project management, medical writing, regulatory compliance, and clinical protocol design. The group operates from United States.
Executive Information
Name
Title
Email
Tom Ludlam
Dir., CEO, Pres.
N/A
Richard Gams
Founder, Chief Scientific Officer, Chief Medical Officer
